HDL PARTICLE CONCENTRATION IS NOT ASSOCIATED WITH RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS FOLLOWING ACUTE CORONARY SYNDROMES

Abstract

Drugs to raise HDL cholesterol (HDL-C) have generally failed to decrease major adverse cardiovascular events (MACE). HDL particle concentration (HDLP) has been proposed as a better predictor of MACE than HDL-C. We determined whether HDLP is associated with risk of MACE after acute coronary syndrome